LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 843 | 663 | 1.2707 | 1.1682 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 416 | 663 | 0.6271 | 0.7088 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1150 | 663 | 1.7335 | 1.4076 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 1083 | 766 | 1.4123 | 1.2297 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 856 | 766 | 1.1162 | 1.0705 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 664 | 766 | 0.8659 | 0.9113 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 1164 | 766 | 1.5179 | 1.2809 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 1 | 898 | 0.0011 | -0.7287 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 1100 | 898 | 1.2236 | 1.1221 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 2 | 898 | 0.0022 | -0.6675 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 898 | 898 | 0.9989 | 0.9994 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 736 | 898 | 0.8187 | 0.8859 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 1178 | 898 | 1.3104 | 1.1653 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 1 | 1239 | 0.0008 | -0.6828 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 1125 | 1239 | 0.9077 | 0.9505 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 4 | 1239 | 0.0032 | -0.5461 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 927 | 1239 | 0.7479 | 0.8553 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 1098 | 1239 | 0.8859 | 0.9383 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 19.69 | 84.90 | 1223 | 1239 | 0.9868 | 0.9931 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 1 | 1454 | 0.0007 | -0.6616 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 1166 | 1454 | 0.8016 | 0.8949 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 6 | 1454 | 0.0041 | -0.4761 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 954 | 1454 | 0.6558 | 0.8044 | MN20160318_Q02 | H20 |